These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
305 related items for PubMed ID: 17547898
1. Endometrial cells identified in cervical cytology in women > or = 40 years of age: criteria for appropriate endometrial evaluation. Beal HN, Stone J, Beckmann MJ, McAsey ME. Am J Obstet Gynecol; 2007 Jun; 196(6):568.e1-5; discussion 568.e5-6. PubMed ID: 17547898 [Abstract] [Full Text] [Related]
4. Reporting endometrial cells in women 40 years and older: assessing the clinical usefulness of Bethesda 2001. Simsir A, Carter W, Elgert P, Cangiarella J. Am J Clin Pathol; 2005 Apr; 123(4):571-5. PubMed ID: 15743742 [Abstract] [Full Text] [Related]
5. Routine endometrial sampling of asymptomatic premenopausal women shedding normal endometrial cells in Papanicolaou tests is not cost effective. Kapali M, Agaram NP, Dabbs D, Kanbour A, White S, Austin RM. Cancer; 2007 Feb 25; 111(1):26-33. PubMed ID: 17262796 [Abstract] [Full Text] [Related]
8. The clinical significance of benign-appearing endometrial cells on a Papanicolaou test in women 40 years or older. Browne TJ, Genest DR, Cibas ES. Am J Clin Pathol; 2005 Dec 25; 124(6):834-7. PubMed ID: 16416731 [Abstract] [Full Text] [Related]
11. Significance of "normal" endometrial cells in cervical cytology from asymptomatic postmenopausal women receiving hormone replacement therapy. Montz FJ. Gynecol Oncol; 2001 Apr 25; 81(1):33-9. PubMed ID: 11277646 [Abstract] [Full Text] [Related]
12. In Papanicolaou smears, benign appearing endometrial cells bear no significance in predicting uterine endometrial adenocarcinomas. Moatamed NA, Le LT, Levin MR, Govind R, Apple SK. Diagn Cytopathol; 2013 Apr 25; 41(4):335-41. PubMed ID: 22102567 [Abstract] [Full Text] [Related]
13. The Bethesda System 2001 recommendation for reporting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinical qualifiers. Aslan DL, Crapanzano JP, Harshan M, Erroll M, Vakil B, Pirog EC. Gynecol Oncol; 2007 Oct 25; 107(1):86-93. PubMed ID: 17604086 [Abstract] [Full Text] [Related]
15. High risk of cervical pathology among women with postmenopausal bleeding and endometrium <or=4.4 mm: long-term follow-up results. Epstein E, Jamei B, Lindqvist PG. Acta Obstet Gynecol Scand; 2006 Oct 25; 85(11):1368-74. PubMed ID: 17091419 [Abstract] [Full Text] [Related]
16. Significance of benign endometrial cells in papanicolaou tests from women aged >or=40 years. Thrall MJ, Kjeldahl KS, Savik K, Gulbahce HE, Pambuccian SE. Cancer; 2005 Aug 25; 105(4):207-16. PubMed ID: 15900572 [Abstract] [Full Text] [Related]
17. Cervical and vaginal cytologic smears suggestive of adenocarcinoma. Pretorius R, Binstock M, Sadeghi M, Hodges W. J Reprod Med; 1996 Jul 25; 41(7):478-82. PubMed ID: 8829059 [Abstract] [Full Text] [Related]
19. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy]. Hauth E, Libera H, Kimmig R, Forsting M. Rofo; 2006 Mar 25; 178(3):316-23. PubMed ID: 16508840 [Abstract] [Full Text] [Related]
20. Differential indication for histological evaluation of endometrial fluid in postmenopause. Schmidt T, Nawroth F, Breidenbach M, Hoopmann M, Mallmann P, Valter MM. Maturitas; 2005 Mar 14; 50(3):177-81. PubMed ID: 15734598 [Abstract] [Full Text] [Related] Page: [Next] [New Search]